+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gilead Sciences Inc - logo

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

Tracheitis Treatment Market Report 2025 - Product Thumbnail Image

Tracheitis Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
Pulmonary Embolism Therapeutics Market 2024-2028 - Product Thumbnail Image

Pulmonary Embolism Therapeutics Market 2024-2028

  • Report
  • July 2024
  • 164 Pages
  • Global
From
Pulmonary Arterial Hypertension (PAH) Drugs Market 2024-2028 - Product Thumbnail Image

Pulmonary Arterial Hypertension (PAH) Drugs Market 2024-2028

  • Report
  • July 2024
  • 180 Pages
  • Global
From
From
From
Pharmaceutical Drugs Market Report 2025 - Product Thumbnail Image

Pharmaceutical Drugs Market Report 2025

  • Report
  • March 2025
  • 400 Pages
  • Global
From
Sickle Cell Disease- Pipeline Insight, 2025 - Product Thumbnail Image

Sickle Cell Disease- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
From
From
Sickle Cell Disease Treatment Market Report 2025 - Product Thumbnail Image

Sickle Cell Disease Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Polycythemia Vera Market Report and Forecast 2024-2032 - Product Thumbnail Image

Polycythemia Vera Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 180 Pages
  • Global
From
From
From
From
Loading Indicator